ShenDDOjemannGARapportRLDillsRLFrielPNLevyRH. Low and variable presence of valproic acid in human brain. Neurology1992;42: 582–5.
2.
MorikawaNMoriTKawashimaHFujikiMAbeTKakuTPharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors. Eur J Clin Pharmacol1998;54:415–20.
3.
VajdaFJDonnanGAPhilippsJBladinPF. Human brain, plasma, and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy. Neurology1981;31: 486–7.
4.
FreyH-HLoscherW. Distribution of valproate across the interface between blood and cerebrospinal fluid. Neurol Pharmacol1978;17: 637–42.
